Commercial Channels

Branded as Fusion, a new IT platform is offered to improve patient hub services

Global Health and Wellness Survey tracks diagnoses, level of therapeutic treatment

‘Relationship Analytics’ uses prescriber data to map affiliations and interests

‘An unaffordable drug is 100 percent ineffective’

Kiosks sit in physicians’ offices for sample drop-offs

“Cold chain” now means cryogenic and ambient shipping, as well as the traditional 2–8° range

Commission issues interim report with numerous calls to action, while manufacturers and distributors contend with multiple DEA penalties

An estimated 64,070 deaths recorded; meanwhile, private equity flows into addiction centers

Pharma needs better internal policies to manage its increasing patient interaction

Oncology, obesity control and respiratory therapy are the first targets

Cambridge BioMarketing brings orphan-drug expertise, and Vynamic brings branding and launch services

Like traditional thinking about key opinion leaders (KOLs) in healthcare, consider the DOL as part of a marketing campaign

Big Data analytics combined with fresh formulary data

Novartis, Pfizer and Roche will run neck-and-neck for global leader spot

Salesforce.com annual poll finds support for digital assistants and sharing health data

Context Matters Inc. and IHS Markit provide analytics on pricing strategies

Marketing strategies will adjust with the advent of biosimilars

An ‘overwhelming’ information load is affecting oncology’s ability to develop successful treatment pathways

Peer-to-peer network enables docs to discuss drug performance, especially of new launches

EMD Serono Specialty Digest finds they struggle over 'ensuring clinically appropriate use'

Less drug waste, fewer ER visits can offset high drug costs

Cutting Edge report finds continued growth in headcount

Despite the buzz around digital media channels, pharma continues to pour marketing dollars into television

Industry insider Nitin Sahney returns with PharmaCord

IPC and Pace Alliance will combine on April 1

LexisNexis Health Care analyzes affiliation data on healthcare providers

Drug-based therapies for opioid dependency gain acceptance and reimbursement

Interchangeability will require ‘switching studies’ and postmarketing surveillance

Brand manufacturers retain 47% of net expenditures for drugs